Sleep drug may increase risk of falls, study finds

11/20/2012 | U.S. News & World Report

Mayo Clinic researchers examined data on more than 16,000 hospitalized patients in the U.S., and found that those who received the sleeping pill Ambien, or zolpidem, fell at a rate four times greater than those who didn't receive the treatment. Due to the research, Mayo is transitioning to other sleep-enhancement treatments, said Dr. Timothy Morgenthaler, Mayo's chief patient safety officer.

View Full Article in:

U.S. News & World Report

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park